GAMMA Investing’s Greenwich LifeSciences GLSI Stock Holding History

GAMMA Investing’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36K	Buy	58 +31	+115%	+$754	﹤0.01%	3810
2026 Q1	$649	Buy	+27	New	+$704	﹤0.01%	3909
2025 Q2	–	Sell	-126	Closed	-$1.2K	–	3826
2025 Q1	$1.2K	Buy	+126	New	+$1.53K	﹤0.01%	3526

Other funds holding GLSI

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SIC

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

GAMMA Investing's GLSI Position: Q2 2026 in Review

GAMMA Investing increased its Greenwich LifeSciences (GLSI) stake by 115% in Q2 2026, buying an estimated $754 and bringing the position to 58 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #3810.

GAMMA Investing first reported a position in GLSI in Q1 2025 and has held it in 3 quarters since. 5 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

GAMMA Investing held 58 shares of Greenwich LifeSciences worth $1.36K as of Q2 2026.
GAMMA Investing bought 31 Greenwich LifeSciences shares in Q2 2026, an estimated $754.
Greenwich LifeSciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3810 holding.
GAMMA Investing first reported a position in Greenwich LifeSciences in Q1 2025 and has held it in 3 quarters since.
5 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.